OBJECTIVE: To evaluate the effectiveness of screening strategy and contact precautions for patients with methicillin-resistant Staphylococcus aureus (MRSA). DESIGN AND SETTING: Prospective observational cohort from 1 February 1995 to 31 December 2001 in three intensive care units (45 beds) in a French teaching hospital. PATIENTS: 8,548 patients admitted to the three ICUs had nasal screening on ICU admission and weekly thereafter. Contact precautions were used in MRSA-positive patients. The following variables were collected: age, gender, severity score, length of stay, workload, and colonization pressure (percentage of patient-days with an MRSA to the number of patient-days in the unit). Alcohol-based handrub solution was introduced in July 2000. We compared the period before this (P1) with that thereafter (P2). RESULTS: Of the 8,548 admitted patients 554 (6.5%) had MRSA at ICU admission, and 456 of the 7,515 (6.1%) exposed patients acquired MRSA. Acquisition incidence decreased from 7.0% in P1 to 2.8% in P2. Independent variables associated with MRSA acquisition were: age (adjusted odds ratio 1.013), severity score (1.047), length of ICU stay (1.015), colonization pressure (1.019), medical ICU (1.58), and P2 (0.49). CONCLUSIONS: MRSA control in these ICUs characterized by a high prevalence of MRSA at admission was achieved via multiple factors, including screening, contact precautions, and use of alcoholic handrub solution. Our results after adjustment of risk factors for MRSA acquisition and the steady improvement in MRSA over several years strengthen these findings. MRSA spreading can be successfully controlled in ICUs with high colonization pressure.
OBJECTIVE: To evaluate the effectiveness of screening strategy and contact precautions for patients with methicillin-resistant Staphylococcus aureus (MRSA). DESIGN AND SETTING: Prospective observational cohort from 1 February 1995 to 31 December 2001 in three intensive care units (45 beds) in a French teaching hospital. PATIENTS: 8,548 patients admitted to the three ICUs had nasal screening on ICU admission and weekly thereafter. Contact precautions were used in MRSA-positive patients. The following variables were collected: age, gender, severity score, length of stay, workload, and colonization pressure (percentage of patient-days with an MRSA to the number of patient-days in the unit). Alcohol-based handrub solution was introduced in July 2000. We compared the period before this (P1) with that thereafter (P2). RESULTS: Of the 8,548 admitted patients 554 (6.5%) had MRSA at ICU admission, and 456 of the 7,515 (6.1%) exposed patients acquired MRSA. Acquisition incidence decreased from 7.0% in P1 to 2.8% in P2. Independent variables associated with MRSA acquisition were: age (adjusted odds ratio 1.013), severity score (1.047), length of ICU stay (1.015), colonization pressure (1.019), medical ICU (1.58), and P2 (0.49). CONCLUSIONS: MRSA control in these ICUs characterized by a high prevalence of MRSA at admission was achieved via multiple factors, including screening, contact precautions, and use of alcoholic handrub solution. Our results after adjustment of risk factors for MRSA acquisition and the steady improvement in MRSA over several years strengthen these findings. MRSA spreading can be successfully controlled in ICUs with high colonization pressure.
Authors: Carlene A Muto; John A Jernigan; Belinda E Ostrowsky; Hervé M Richet; William R Jarvis; John M Boyce; Barry M Farr Journal: Infect Control Hosp Epidemiol Date: 2003-05 Impact factor: 3.254
Authors: J Merrer; F Santoli; C Appéré de Vecchi; B Tran; B De Jonghe; H Outin Journal: Infect Control Hosp Epidemiol Date: 2000-11 Impact factor: 3.254
Authors: R Coello; J Jiménez; M García; P Arroyo; D Minguez; C Fernández; F Cruzet; C Gaspar Journal: Eur J Clin Microbiol Infect Dis Date: 1994-01 Impact factor: 3.267
Authors: John M Boyce; Nancy L Havill; Cynthia Kohan; Diane G Dumigan; Catherine E Ligi Journal: Infect Control Hosp Epidemiol Date: 2004-05 Impact factor: 3.254
Authors: Adebola O Ajao; Anthony D Harris; Mary-Claire Roghmann; J Kristie Johnson; Min Zhan; Jessina C McGregor; Jon P Furuno Journal: Infect Control Hosp Epidemiol Date: 2011-05 Impact factor: 3.254
Authors: J R Zahar; M Garrouste-Orgeas; A Vesin; C Schwebel; A Bonadona; F Philippart; C Ara-Somohano; B Misset; J F Timsit Journal: Intensive Care Med Date: 2013-08-31 Impact factor: 17.440
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker Journal: Intensive Care Med Date: 2006-02-17 Impact factor: 17.440
Authors: Håkan Hanberger; Dilek Arman; Hans Gill; Vlastimil Jindrák; Smilja Kalenic; Andrea Kurcz; Monica Licker; Paul Naaber; Elizabeth A Scicluna; Václav Vanis; Sten M Walther Journal: Intensive Care Med Date: 2008-08-01 Impact factor: 17.440
Authors: James A McKinnell; Loren G Miller; Samantha J Eells; Eric Cui; Susan S Huang Journal: Infect Control Hosp Epidemiol Date: 2013-08-19 Impact factor: 3.254
Authors: W Charles Huskins; Charmaine M Huckabee; Naomi P O'Grady; Patrick Murray; Heather Kopetskie; Louise Zimmer; Mary Ellen Walker; Ronda L Sinkowitz-Cochran; John A Jernigan; Matthew Samore; Dennis Wallace; Donald A Goldmann Journal: N Engl J Med Date: 2011-04-14 Impact factor: 91.245
Authors: Axel Kramer; Hans Wagenvoort; Christina Ahrén; Inka Daniels-Haardt; Philippe Hartemann; Hiro Kobayashi; Andrea Kurcz; Juan Picazo; Gaetano Privitera; Ojan Assadian Journal: GMS Krankenhhyg Interdiszip Date: 2010-02-10
Authors: Elise M Martin; Dana Russell; Zachary Rubin; Romney Humphries; Tristan R Grogan; David Elashoff; Daniel Z Uslan Journal: Infect Control Hosp Epidemiol Date: 2016-07-26 Impact factor: 3.254